Hookipa Pharma EVP Coelho sells $12,520 in shares
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hookipa Pharma Inc (HOOK)
Hookipa Pharma Inc stock price live, this page displays OTC HOOK stock exchange data. View the HOOK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hookipa Pharma Inc real time stock price chart below.
What Is the Hookipa Pharma Inc Stock Price Today?
The Hookipa Pharma Inc stock price today is 0.8805.
What Is the Stock Symbol for Hookipa Pharma Inc?
The stock symbol for Hookipa Pharma Inc is ""HOOK.""
What Stock Exchange Does Hookipa Pharma Inc Trade On?
Hookipa Pharma Inc is listed and trades on the OTC Markets stock exchange.
Is Hookipa Pharma Inc a Good Stock to Buy?
Determining whether Hookipa Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HOOK quote. (ISIN: US43906K2096)
What Is the Hookipa Pharma Inc Stock Price Today?
The Hookipa Pharma Inc stock price today is 0.8805.
What Is the Stock Symbol for Hookipa Pharma Inc?
The stock symbol for Hookipa Pharma Inc is ""HOOK.""
What Stock Exchange Does Hookipa Pharma Inc Trade On?
Hookipa Pharma Inc is listed and trades on the OTC Markets stock exchange.
Is Hookipa Pharma Inc a Good Stock to Buy?
Determining whether Hookipa Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HOOK quote. (ISIN: US43906K2096)
OTC Markets
Currency in USD
0.8805
+0.0402(+4.78%)
Closed·
Fair Value
An estimate of a Hookipa Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8110
0.9400
52 wk Range
0.7210
5.6600
HOOK Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
HOOK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Hookipa Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.81100.9400
52 wk Range
0.72105.6600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HOOK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hookipa Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Hookipa Pharma EVP Coelho sells $12,520 in shares
- Investing.com
- Form 8K Hookipa Pharma Inc For: 22 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Hookipa Pharma Inc Company Profile
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company’s immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Hookipa Pharma Inc SWOT Analysis
Strategic Pivot | HOOKIPA's 80% workforce reduction and pausing of lead program signal a major shift towards focusing on high-potential areas like the HB-700 KRAS vaccine |
Pipeline Prospects | Explore HOOKIPA's ongoing collaborations with Gilead Sciences in HIV and HBV vaccines, offering potential milestone payments and royalties |
Financial Challenges | Delve into HOOKIPA's financial position, with cash reserves and partnerships offsetting concerns about long-term stability and weak profit margins |
Market Outlook | Analyst price targets range from $5 to $48, reflecting mixed sentiments on HOOKIPA's future amid restructuring and pipeline developments |
Compare HOOK to Peers and Sector
Metrics to compare | HOOK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHOOKPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −1.6x | −0.5x | |
PEG Ratio | 0.00 | −0.03 | 0.00 | |
Price/Book | 0.3x | 0.8x | 2.6x | |
Price / LTM Sales | 1.2x | 41.6x | 3.3x | |
Upside (Analyst Target) | 127.1% | 246.8% | 43.5% | |
Fair Value Upside | Unlock | 34.8% | 6.8% | Unlock |
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-1.23 / -0.17
Revenue / Forecast
2.00M / 2.00M
People Also Watch
FAQ
What Stock Exchange Does Hookipa Pharma Trade On?
Hookipa Pharma is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Hookipa Pharma?
The stock symbol for Hookipa Pharma is "HOOK."
What Is the Hookipa Pharma Market Cap?
As of today, Hookipa Pharma market cap is 10.91M.
What Is Hookipa Pharma's Earnings Per Share (TTM)?
The Hookipa Pharma EPS (TTM) is -5.85.
From a Technical Analysis Perspective, Is HOOK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hookipa Pharma Stock Split?
Hookipa Pharma has split 1 times.
How Many Employees Does Hookipa Pharma Have?
Hookipa Pharma has 85 employees.
What is the current trading status of Hookipa Pharma (HOOK)?
As of 09 Aug 2025, Hookipa Pharma (HOOK) is trading at a price of 0.88, with a previous close of 0.84. The stock has fluctuated within a day range of 0.81 to 0.94, while its 52-week range spans from 0.72 to 5.66.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.